These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10099057)

  • 21. Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador.
    Elluru S; Duong Van Huyen JP; Delignat S; Prost F; Bayry J; Kazatchkine MD; Kaveri SV
    Arzneimittelforschung; 2006 Jun; 56(6A):461-6. PubMed ID: 16927527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
    Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease of activated lymphocytes four and nine hours after a subcutaneous injection of a Viscum album L. extract in healthy volunteers.
    Stoss M; Peter E; Gorter RW
    Nat Immun; 1998; 16(5-6):185-97. PubMed ID: 11061587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of 20-methylcholanthrene-induced sarcoma by a mistletoe extract, Iscador.
    Kuttan G; Menon LG; Kuttan R
    Carcinogenesis; 1996 May; 17(5):1107-9. PubMed ID: 8640920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No evidence of IFN-gamma increase in the serum of HIV-positive and healthy subjects after subcutaneous injection of a non-fermented viscum album L. extract.
    Stoss M; Gorter RW
    Nat Immun; 1998; 16(4):157-64. PubMed ID: 10366786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in immunological characteristics of white blood cells after administration of standardized mistletoe extract.
    Klopp R; Schmidt W; Niemer W; Werner M; Beuth J
    In Vivo; 2001; 15(6):447-57. PubMed ID: 11887328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Iscador preparations on the reactivity of mouse immune system.
    Gren A
    Neuro Endocrinol Lett; 2009; 30(4):530-4. PubMed ID: 20010495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador.
    Maldacker J
    Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
    Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
    Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 May; 158(9):1157-9. PubMed ID: 9597967
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytostatic and cytocidal effects of mistletoe (Viscum album L.) quercus extract Iscador.
    Kovacs E; Link S; Toffol-Schmidt U
    Arzneimittelforschung; 2006 Jun; 56(6A):467-73. PubMed ID: 16927528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract.
    Finall AI; McIntosh SA; Thompson WD
    BMJ; 2006 Dec; 333(7582):1293-4. PubMed ID: 17185712
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro immunoreactivity towards lectin-rich or viscotoxin-rich mistletoe (Viscum album L.) extracts Iscador applied to healthy individuals.
    Huber R; Classen K; Werner M; Klein R
    Arzneimittelforschung; 2006 Jun; 56(6A):447-56. PubMed ID: 16927525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study.
    Kim KC; Yook JH; Eisenbraun J; Kim BS; Huber R
    BMC Complement Altern Med; 2012 Oct; 12():172. PubMed ID: 23033982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of metastatic malignant melanoma with Viscum album extract (Iscador M).
    Kirsch A
    J Altern Complement Med; 2007 May; 13(4):443-5. PubMed ID: 17532738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
    Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
    Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the effect of mistletoe (Viscum album L.) extract Iscador on the proliferation and apoptosis of murine thymocytes.
    Hajtò T; Berki T; Pàlinkàs L; Boldizsàr F; Németh P
    Arzneimittelforschung; 2006 Jun; 56(6A):441-6. PubMed ID: 16927524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects.
    Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Buck S; Klein R
    Eur J Med Res; 2005 Oct; 10(10):411-8. PubMed ID: 16287602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.